Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating pharmacokinetics and pharmacodynamics of a new nasal naloxone formulation for prehospital use in drug overdose situations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug Overdose

Drugs mentioned

• nasal naloxone (new formulation) (naloxone)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Drug Overdose | Phase 1, Phase 2 | Status: COMPLETED